$0.2332
-0.03-10.34%
At close: -
$0.2190
-0.01-6.09%
After Hours: 7:59 PM EDT
Comments
Loading...
Quoin Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:QNRX | Benzinga
Quoin Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.420
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Quoin Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| QNRX | Quoin Pharmaceuticals | -$1.11 | -$0.42 | — | — | $0.00 | — | — | — | 05/08/2025 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$2.08 | -$0.43 | -$0.35 | 18.60% | $0.00 | — | $0.00 | — | 03/13/2025 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$1.95 | -$0.49 | -$0.47 | 4.08% | $0.00 | — | $0.00 | — | 11/07/2024 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$2.13 | -$0.61 | -$0.39 | 36.07% | $0.00 | — | $0.00 | — | 08/08/2024 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$4.09 | -$0.76 | -$1.11 | -46.05% | $0.00 | — | $0.00 | — | 05/09/2024 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$4.92 | -$2.31 | -$2.08 | 9.96% | $0.00 | — | $0.00 | — | 03/13/2024 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$11.28 | -$2.72 | -$1.95 | 28.31% | $0.00 | — | $0.00 | — | 11/08/2023 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$38.88 | -$2.82 | -$2.13 | 24.47% | $0.00 | — | $0.00 | — | 08/02/2023 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$2.40 | -$3.36 | -$4.08 | -21.43% | $0.00 | — | $0.00 | — | 05/08/2023 | Get Alert |
| QNRX | Quoin Pharmaceuticals | — | -$7.44 | -$4.92 | 33.87% | — | — | $0.00 | — | 03/08/2023 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$16.80 | — | -$11.28 | — | $0.00 | — | $0.00 | — | 11/10/2022 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$0.00 | — | -$38.88 | — | $0.00 | — | $0.00 | — | 08/18/2022 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$0.00 | — | -$2.40 | — | $0.00 | — | $0.00 | — | 05/23/2022 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$0.00 | — | — | — | $0.00 | — | — | — | 04/22/2022 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$0.00 | — | -$16.80 | — | $0.00 | — | $0.00 | — | 12/20/2021 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$0.01 | — | -$0.00 | — | $0.00 | — | $0.00 | — | 08/24/2021 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$0.00 | — | -$0.00 | — | $0.00 | — | $0.00 | — | 05/17/2021 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$0.01 | — | -$0.00 | — | $0.00 | — | $0.00 | — | 03/29/2021 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$0.12 | — | -$0.00 | — | $0.00 | — | $0.00 | — | 11/20/2020 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$0.01 | — | -$0.01 | — | $0.00 | — | $0.00 | — | 08/12/2020 | Get Alert |
| QNRX | Quoin Pharmaceuticals | -$0.16 | — | -$0.00 | — | — | — | $0.00 | — | 05/21/2020 | Get Alert |
Quoin Pharmaceuticals (QNRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-13 | $-0.35 | $-0.43 | 18.6 % |
| Q3 | 2024-11-07 | $-0.47 | $-0.49 | 4.08 % |
| Q2 | 2024-08-08 | $-0.39 | $-0.61 | 36.1 % |
| Q1 | 2024-05-09 | $-1.11 | $-0.76 | -46.1 % |
Quoin Pharmaceuticals (QNRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Quoin Pharmaceuticals (NASDAQ:QNRX) reporting earnings?
Quoin Pharmaceuticals (QNRX) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 13, 2025 for Q4.
What were the latest earnings per share (EPS) for Quoin Pharmaceuticals (NASDAQ:QNRX)?
The Actual EPS was $-0.35, which beat the estimate of $-0.43.
What were Quoin Pharmaceuticals’s (NASDAQ:QNRX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.